Prevalence of anaemia in women screening for participation in a microbicide trial and the follow-up: a public health benefit.

From:
Department for International Development
Published
1 January 2008
Country:
South Africa
Document Type:
Conference Paper
Theme:
Health
Authors:
Asmal, H.

Abstract

Anaemia is a common medical condition. Most anaemias go undetected until symptomatic. MDP 301 is a phase III microbicide trial. We conducted this study to determine prevalence of anaemia at screening and follow-up of enrolled HIV negative women in HPRU, Durban. METHODOLOGY: We conducted a retrospective CRF review of Hb level and HIV status of the first 1000 screening participants. Any Hb

Citation

Asmal, H. Prevalence of anaemia in women screening for participation in a microbicide trial and the follow-up: a public health benefit. Presented at Microbicides 2008, New Delhi, India, 24-27 February 2008. (2008)

Prevalence of anaemia in women screening for participation in a microbicide trial and the follow-up: a public health benefit.

Published 1 January 2008
Contents